ArticleCell communication and signaling : CCS2025
Extracellular domain shedding of NOTCH3 during endocytosis associated with heterogeneity between different CADASIL mutant activation mechanisms.
Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundMutations in NOTCH3 cause CADASIL, a dominantly inherited condition, linked to recurrent stroke and vascular dementia and associated with accumulation of the ECD of NOTCH3. The latter has a toxic effect on VSMCs. Misregulated signalling may also play a role in disease progression. ECD detachment is an obligatory step in NOTCH3 activation, but some CADASIL mutants prevent ligand-induced activation and so ligand interactions are not a common underlying requirement. Here we investigated whether basal NOTCH3 endocytosis that is associated with ligand-independent activation mechanisms can be source of ECD shedding in CADASIL mutants.
methodsWe used transient transfection of hTERT-RPE1 cells to express WT, R90C, C212Y and C455R mutant NOTCH3 constructs. Internalisation of NOTCH3 was followed using a pulse-chase endocytic uptake assay after surface NOTCH3 labelling of live cells. Immunolocalisation of NOTCH3 ECD and ICD was used to define the subcellular localisation of expressed NOTCH3 in the secretory and endocytic pathway of transfected cells, and endogenous NOTCH3 in MCF7 cells and VSMCs derived from human ES cells. To investigate NOTCH3 signalling we used a luciferase reporter assay under control of a NOTCH-responsive reporter element.
resultsBoth WT and CADASIL NOTCH3 proteins are endocytosed before ECD shedding and then undergo dissociation and independent trafficking of the ECD and ICD in the endosome. The relative amount of ICD compared to ECD that colocalised with endosomal markers increases as NOTCH3 progresses through the endosomal trafficking pathway from early endosome to lysosome. The R90C mutant showed earlier separation of ECD compared to WT or other CADASIL mutants tested. All WT and mutant constructs activated downstream signalling when expressed in hTERT-RPE1 cells, and these basal signalling levels were not affected by the C455R mutation which removes ligand-activated signalling. R90C showed distinctly different requirements for activation being less sensitive to metalloprotease inhibition and more sensitive to inhibition of the lysosomal protein TRPML.
conclusionsBasal NOTCH3 endocytosis and signalling is a potential source of ECD shedding and accumulation in CADASIL. Different mechanisms may apply to different CADASIL mutants and understanding the variety of mechanisms by which NOTCH3 signalling and ECD shedding occur will inform new targeted approaches to treatments of small vessel disease. Tuning NOTCH3 activity through modulation of the endocytic pathway may offer better tolerated approaches than direct targeting of NOTCH3 signalling.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.